Investor profile
Ouali Omani
Angel, Syndicate / Angel group & Global Commercialisation Strategy Leader at Roche
Ouali Omani is an angel investor and syndicate member based in Basel, Switzerland. The known portfolio is one company, temtem.
Is Ouali Omani a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Contacts
Ouali Omani portfolio company (1)
- temtem
Affiliated funds' portfolios
Global Commercialisation Strategy Leader at Roche, whose known portfolio counts 14 companies
- Freenome
- C4 Therapeutics
- Splice Bio
- GlycoEra
- Flatiron Health
- MISSION Therapeutics
- NMD Pharma
- Cour Pharmaceuticals Development
- Proacta
- Affimed
- DiogenX
- Mironid
- and 2 more
Investor Profile
The portfolio and focus above give founders context on whether Ouali Omani matches their raise.
Colleagues at Roche
Similar investors
Showing 20 of 100
Frequently asked questions
Who is Ouali Omani?
Ouali Omani is an angel investor and syndicate member based in Basel, Switzerland with one known investment on file, temtem. The sections above list the firms attached to that record.
Which firm is Ouali Omani listed at?
Ouali Omani is listed as Global Commercialisation Strategy Leader at Roche. 8 other people in the database share a firm with Ouali Omani.
How do I contact Ouali Omani?
A LinkedIn page is on file for Ouali Omani. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal
